COVID-19 Impact on Global Musculoskeletal Disorders Therapeutics Market Size, Status and Forecast 2020-2026

September 2020 | 128 pages | ID: CD58A9E94696EN
QYResearch

Abstracts

This report focuses on the global Musculoskeletal Disorders Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Musculoskeletal Disorders Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• AbbVie
• Johnson & Johnson
• Amgen
• Pfizer
• F. Hoffmann-La Roche
• Eli Lilly
• Merck
• Novartis
• AstraZeneca
• Astellas
• AB Sciences
• 3SBio
• Samsung Bioepis
• Sanofi
• Taisho Pharmaceutical
• Takeda
• Zosano Pharma
• LG Life Sciences

Market segment by Type, the product can be split into

• Biologics
• Small Molecules

Market segment by Application, split into

• Osteoarthritis
• Osteoporosis
• Psoriatic Arthritis
• Ankylosing Spondylitis
• Fibromyalgia

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Musculoskeletal Disorders Therapeutics status, future forecast, growth opportunity, key market and key players.
• To present the Musculoskeletal Disorders Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Musculoskeletal Disorders Therapeutics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Musculoskeletal Disorders Therapeutics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Musculoskeletal Disorders Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Biologics
  1.4.3 Small Molecules
1.5 Market by Application
  1.5.1 Global Musculoskeletal Disorders Therapeutics Market Share by Application: 2020 VS 2026
  1.5.2 Osteoarthritis
  1.5.3 Osteoporosis
  1.5.4 Psoriatic Arthritis
  1.5.5 Ankylosing Spondylitis
  1.5.6 Fibromyalgia
1.6 Coronavirus Disease 2019 (Covid-19): Musculoskeletal Disorders Therapeutics Industry Impact
  1.6.1 How the Covid-19 is Affecting the Musculoskeletal Disorders Therapeutics Industry
    1.6.1.1 Musculoskeletal Disorders Therapeutics Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Musculoskeletal Disorders Therapeutics Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Musculoskeletal Disorders Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Musculoskeletal Disorders Therapeutics Market Perspective (2015-2026)
2.2 Musculoskeletal Disorders Therapeutics Growth Trends by Regions
  2.2.1 Musculoskeletal Disorders Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Musculoskeletal Disorders Therapeutics Historic Market Share by Regions (2015-2020)
  2.2.3 Musculoskeletal Disorders Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Musculoskeletal Disorders Therapeutics Market Growth Strategy
  2.3.6 Primary Interviews with Key Musculoskeletal Disorders Therapeutics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Musculoskeletal Disorders Therapeutics Players by Market Size
  3.1.1 Global Top Musculoskeletal Disorders Therapeutics Players by Revenue (2015-2020)
  3.1.2 Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Musculoskeletal Disorders Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Musculoskeletal Disorders Therapeutics Market Concentration Ratio
  3.2.1 Global Musculoskeletal Disorders Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Musculoskeletal Disorders Therapeutics Revenue in 2019
3.3 Musculoskeletal Disorders Therapeutics Key Players Head office and Area Served
3.4 Key Players Musculoskeletal Disorders Therapeutics Product Solution and Service
3.5 Date of Enter into Musculoskeletal Disorders Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Musculoskeletal Disorders Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Musculoskeletal Disorders Therapeutics Forecasted Market Size by Type (2021-2026)

5 MUSCULOSKELETAL DISORDERS THERAPEUTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Musculoskeletal Disorders Therapeutics Market Size by Application (2015-2020)
5.2 Global Musculoskeletal Disorders Therapeutics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Musculoskeletal Disorders Therapeutics Market Size (2015-2020)
6.2 Musculoskeletal Disorders Therapeutics Key Players in North America (2019-2020)
6.3 North America Musculoskeletal Disorders Therapeutics Market Size by Type (2015-2020)
6.4 North America Musculoskeletal Disorders Therapeutics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Musculoskeletal Disorders Therapeutics Market Size (2015-2020)
7.2 Musculoskeletal Disorders Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Musculoskeletal Disorders Therapeutics Market Size by Type (2015-2020)
7.4 Europe Musculoskeletal Disorders Therapeutics Market Size by Application (2015-2020)

8 CHINA

8.1 China Musculoskeletal Disorders Therapeutics Market Size (2015-2020)
8.2 Musculoskeletal Disorders Therapeutics Key Players in China (2019-2020)
8.3 China Musculoskeletal Disorders Therapeutics Market Size by Type (2015-2020)
8.4 China Musculoskeletal Disorders Therapeutics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Musculoskeletal Disorders Therapeutics Market Size (2015-2020)
9.2 Musculoskeletal Disorders Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Musculoskeletal Disorders Therapeutics Market Size by Type (2015-2020)
9.4 Japan Musculoskeletal Disorders Therapeutics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Musculoskeletal Disorders Therapeutics Market Size (2015-2020)
10.2 Musculoskeletal Disorders Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Musculoskeletal Disorders Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Musculoskeletal Disorders Therapeutics Market Size by Application (2015-2020)

11 INDIA

11.1 India Musculoskeletal Disorders Therapeutics Market Size (2015-2020)
11.2 Musculoskeletal Disorders Therapeutics Key Players in India (2019-2020)
11.3 India Musculoskeletal Disorders Therapeutics Market Size by Type (2015-2020)
11.4 India Musculoskeletal Disorders Therapeutics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Musculoskeletal Disorders Therapeutics Market Size (2015-2020)
12.2 Musculoskeletal Disorders Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Musculoskeletal Disorders Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Musculoskeletal Disorders Therapeutics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 AbbVie
  13.1.1 AbbVie Company Details
  13.1.2 AbbVie Business Overview and Its Total Revenue
  13.1.3 AbbVie Musculoskeletal Disorders Therapeutics Introduction
  13.1.4 AbbVie Revenue in Musculoskeletal Disorders Therapeutics Business (2015-2020))
  13.1.5 AbbVie Recent Development
13.2 Johnson & Johnson
  13.2.1 Johnson & Johnson Company Details
  13.2.2 Johnson & Johnson Business Overview and Its Total Revenue
  13.2.3 Johnson & Johnson Musculoskeletal Disorders Therapeutics Introduction
  13.2.4 Johnson & Johnson Revenue in Musculoskeletal Disorders Therapeutics Business (2015-2020)
  13.2.5 Johnson & Johnson Recent Development
13.3 Amgen
  13.3.1 Amgen Company Details
  13.3.2 Amgen Business Overview and Its Total Revenue
  13.3.3 Amgen Musculoskeletal Disorders Therapeutics Introduction
  13.3.4 Amgen Revenue in Musculoskeletal Disorders Therapeutics Business (2015-2020)
  13.3.5 Amgen Recent Development
13.4 Pfizer
  13.4.1 Pfizer Company Details
  13.4.2 Pfizer Business Overview and Its Total Revenue
  13.4.3 Pfizer Musculoskeletal Disorders Therapeutics Introduction
  13.4.4 Pfizer Revenue in Musculoskeletal Disorders Therapeutics Business (2015-2020)
  13.4.5 Pfizer Recent Development
13.5 F. Hoffmann-La Roche
  13.5.1 F. Hoffmann-La Roche Company Details
  13.5.2 F. Hoffmann-La Roche Business Overview and Its Total Revenue
  13.5.3 F. Hoffmann-La Roche Musculoskeletal Disorders Therapeutics Introduction
  13.5.4 F. Hoffmann-La Roche Revenue in Musculoskeletal Disorders Therapeutics Business (2015-2020)
  13.5.5 F. Hoffmann-La Roche Recent Development
13.6 Eli Lilly
  13.6.1 Eli Lilly Company Details
  13.6.2 Eli Lilly Business Overview and Its Total Revenue
  13.6.3 Eli Lilly Musculoskeletal Disorders Therapeutics Introduction
  13.6.4 Eli Lilly Revenue in Musculoskeletal Disorders Therapeutics Business (2015-2020)
  13.6.5 Eli Lilly Recent Development
13.7 Merck
  13.7.1 Merck Company Details
  13.7.2 Merck Business Overview and Its Total Revenue
  13.7.3 Merck Musculoskeletal Disorders Therapeutics Introduction
  13.7.4 Merck Revenue in Musculoskeletal Disorders Therapeutics Business (2015-2020)
  13.7.5 Merck Recent Development
13.8 Novartis
  13.8.1 Novartis Company Details
  13.8.2 Novartis Business Overview and Its Total Revenue
  13.8.3 Novartis Musculoskeletal Disorders Therapeutics Introduction
  13.8.4 Novartis Revenue in Musculoskeletal Disorders Therapeutics Business (2015-2020)
  13.8.5 Novartis Recent Development
13.9 AstraZeneca
  13.9.1 AstraZeneca Company Details
  13.9.2 AstraZeneca Business Overview and Its Total Revenue
  13.9.3 AstraZeneca Musculoskeletal Disorders Therapeutics Introduction
  13.9.4 AstraZeneca Revenue in Musculoskeletal Disorders Therapeutics Business (2015-2020)
  13.9.5 AstraZeneca Recent Development
13.10 Astellas
  13.10.1 Astellas Company Details
  13.10.2 Astellas Business Overview and Its Total Revenue
  13.10.3 Astellas Musculoskeletal Disorders Therapeutics Introduction
  13.10.4 Astellas Revenue in Musculoskeletal Disorders Therapeutics Business (2015-2020)
  13.10.5 Astellas Recent Development
13.11 AB Sciences
  10.11.1 AB Sciences Company Details
  10.11.2 AB Sciences Business Overview and Its Total Revenue
  10.11.3 AB Sciences Musculoskeletal Disorders Therapeutics Introduction
  10.11.4 AB Sciences Revenue in Musculoskeletal Disorders Therapeutics Business (2015-2020)
  10.11.5 AB Sciences Recent Development
13.12 3SBio
  10.12.1 3SBio Company Details
  10.12.2 3SBio Business Overview and Its Total Revenue
  10.12.3 3SBio Musculoskeletal Disorders Therapeutics Introduction
  10.12.4 3SBio Revenue in Musculoskeletal Disorders Therapeutics Business (2015-2020)
  10.12.5 3SBio Recent Development
13.13 Samsung Bioepis
  10.13.1 Samsung Bioepis Company Details
  10.13.2 Samsung Bioepis Business Overview and Its Total Revenue
  10.13.3 Samsung Bioepis Musculoskeletal Disorders Therapeutics Introduction
  10.13.4 Samsung Bioepis Revenue in Musculoskeletal Disorders Therapeutics Business (2015-2020)
  10.13.5 Samsung Bioepis Recent Development
13.14 Sanofi
  10.14.1 Sanofi Company Details
  10.14.2 Sanofi Business Overview and Its Total Revenue
  10.14.3 Sanofi Musculoskeletal Disorders Therapeutics Introduction
  10.14.4 Sanofi Revenue in Musculoskeletal Disorders Therapeutics Business (2015-2020)
  10.14.5 Sanofi Recent Development
13.15 Taisho Pharmaceutical
  10.15.1 Taisho Pharmaceutical Company Details
  10.15.2 Taisho Pharmaceutical Business Overview and Its Total Revenue
  10.15.3 Taisho Pharmaceutical Musculoskeletal Disorders Therapeutics Introduction
  10.15.4 Taisho Pharmaceutical Revenue in Musculoskeletal Disorders Therapeutics Business (2015-2020)
  10.15.5 Taisho Pharmaceutical Recent Development
13.16 Takeda
  10.16.1 Takeda Company Details
  10.16.2 Takeda Business Overview and Its Total Revenue
  10.16.3 Takeda Musculoskeletal Disorders Therapeutics Introduction
  10.16.4 Takeda Revenue in Musculoskeletal Disorders Therapeutics Business (2015-2020)
  10.16.5 Takeda Recent Development
13.17 Zosano Pharma
  10.17.1 Zosano Pharma Company Details
  10.17.2 Zosano Pharma Business Overview and Its Total Revenue
  10.17.3 Zosano Pharma Musculoskeletal Disorders Therapeutics Introduction
  10.17.4 Zosano Pharma Revenue in Musculoskeletal Disorders Therapeutics Business (2015-2020)
  10.17.5 Zosano Pharma Recent Development
13.18 LG Life Sciences
  10.18.1 LG Life Sciences Company Details
  10.18.2 LG Life Sciences Business Overview and Its Total Revenue
  10.18.3 LG Life Sciences Musculoskeletal Disorders Therapeutics Introduction
  10.18.4 LG Life Sciences Revenue in Musculoskeletal Disorders Therapeutics Business (2015-2020)
  10.18.5 LG Life Sciences Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Musculoskeletal Disorders Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Musculoskeletal Disorders Therapeutics Revenue
Table 3. Ranking of Global Top Musculoskeletal Disorders Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Musculoskeletal Disorders Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Biologics
Table 6. Key Players of Small Molecules
Table 7. COVID-19 Impact Global Market: (Four Musculoskeletal Disorders Therapeutics Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Musculoskeletal Disorders Therapeutics Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Musculoskeletal Disorders Therapeutics Players to Combat Covid-19 Impact
Table 12. Global Musculoskeletal Disorders Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Musculoskeletal Disorders Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Musculoskeletal Disorders Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Musculoskeletal Disorders Therapeutics Market Share by Regions (2015-2020)
Table 16. Global Musculoskeletal Disorders Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Musculoskeletal Disorders Therapeutics Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Musculoskeletal Disorders Therapeutics Market Growth Strategy
Table 22. Main Points Interviewed from Key Musculoskeletal Disorders Therapeutics Players
Table 23. Global Musculoskeletal Disorders Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 24. Global Musculoskeletal Disorders Therapeutics Market Share by Players (2015-2020)
Table 25. Global Top Musculoskeletal Disorders Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Musculoskeletal Disorders Therapeutics as of 2019)
Table 26. Global Musculoskeletal Disorders Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Musculoskeletal Disorders Therapeutics Product Solution and Service
Table 29. Date of Enter into Musculoskeletal Disorders Therapeutics Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Musculoskeletal Disorders Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 32. Global Musculoskeletal Disorders Therapeutics Market Size Share by Type (2015-2020)
Table 33. Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Type (2021-2026)
Table 34. Global Musculoskeletal Disorders Therapeutics Market Size Share by Application (2015-2020)
Table 35. Global Musculoskeletal Disorders Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 36. Global Musculoskeletal Disorders Therapeutics Market Size Share by Application (2021-2026)
Table 37. North America Key Players Musculoskeletal Disorders Therapeutics Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Musculoskeletal Disorders Therapeutics Market Share (2019-2020)
Table 39. North America Musculoskeletal Disorders Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 40. North America Musculoskeletal Disorders Therapeutics Market Share by Type (2015-2020)
Table 41. North America Musculoskeletal Disorders Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 42. North America Musculoskeletal Disorders Therapeutics Market Share by Application (2015-2020)
Table 43. Europe Key Players Musculoskeletal Disorders Therapeutics Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Musculoskeletal Disorders Therapeutics Market Share (2019-2020)
Table 45. Europe Musculoskeletal Disorders Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Musculoskeletal Disorders Therapeutics Market Share by Type (2015-2020)
Table 47. Europe Musculoskeletal Disorders Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Musculoskeletal Disorders Therapeutics Market Share by Application (2015-2020)
Table 49. China Key Players Musculoskeletal Disorders Therapeutics Revenue (2019-2020) (Million US$)
Table 50. China Key Players Musculoskeletal Disorders Therapeutics Market Share (2019-2020)
Table 51. China Musculoskeletal Disorders Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 52. China Musculoskeletal Disorders Therapeutics Market Share by Type (2015-2020)
Table 53. China Musculoskeletal Disorders Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 54. China Musculoskeletal Disorders Therapeutics Market Share by Application (2015-2020)
Table 55. Japan Key Players Musculoskeletal Disorders Therapeutics Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Musculoskeletal Disorders Therapeutics Market Share (2019-2020)
Table 57. Japan Musculoskeletal Disorders Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Musculoskeletal Disorders Therapeutics Market Share by Type (2015-2020)
Table 59. Japan Musculoskeletal Disorders Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Musculoskeletal Disorders Therapeutics Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Musculoskeletal Disorders Therapeutics Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Musculoskeletal Disorders Therapeutics Market Share (2019-2020)
Table 63. Southeast Asia Musculoskeletal Disorders Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Musculoskeletal Disorders Therapeutics Market Share by Type (2015-2020)
Table 65. Southeast Asia Musculoskeletal Disorders Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Musculoskeletal Disorders Therapeutics Market Share by Application (2015-2020)
Table 67. India Key Players Musculoskeletal Disorders Therapeutics Revenue (2019-2020) (Million US$)
Table 68. India Key Players Musculoskeletal Disorders Therapeutics Market Share (2019-2020)
Table 69. India Musculoskeletal Disorders Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 70. India Musculoskeletal Disorders Therapeutics Market Share by Type (2015-2020)
Table 71. India Musculoskeletal Disorders Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 72. India Musculoskeletal Disorders Therapeutics Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Musculoskeletal Disorders Therapeutics Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Musculoskeletal Disorders Therapeutics Market Share (2019-2020)
Table 75. Central & South America Musculoskeletal Disorders Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Musculoskeletal Disorders Therapeutics Market Share by Type (2015-2020)
Table 77. Central & South America Musculoskeletal Disorders Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Musculoskeletal Disorders Therapeutics Market Share by Application (2015-2020)
Table 79. AbbVie Company Details
Table 80. AbbVie Business Overview
Table 81. AbbVie Product
Table 82. AbbVie Revenue in Musculoskeletal Disorders Therapeutics Business (2015-2020) (Million US$)
Table 83. AbbVie Recent Development
Table 84. Johnson & Johnson Company Details
Table 85. Johnson & Johnson Business Overview
Table 86. Johnson & Johnson Product
Table 87. Johnson & Johnson Revenue in Musculoskeletal Disorders Therapeutics Business (2015-2020) (Million US$)
Table 88. Johnson & Johnson Recent Development
Table 89. Amgen Company Details
Table 90. Amgen Business Overview
Table 91. Amgen Product
Table 92. Amgen Revenue in Musculoskeletal Disorders Therapeutics Business (2015-2020) (Million US$)
Table 93. Amgen Recent Development
Table 94. Pfizer Company Details
Table 95. Pfizer Business Overview
Table 96. Pfizer Product
Table 97. Pfizer Revenue in Musculoskeletal Disorders Therapeutics Business (2015-2020) (Million US$)
Table 98. Pfizer Recent Development
Table 99. F. Hoffmann-La Roche Company Details
Table 100. F. Hoffmann-La Roche Business Overview
Table 101. F. Hoffmann-La Roche Product
Table 102. F. Hoffmann-La Roche Revenue in Musculoskeletal Disorders Therapeutics Business (2015-2020) (Million US$)
Table 103. F. Hoffmann-La Roche Recent Development
Table 104. Eli Lilly Company Details
Table 105. Eli Lilly Business Overview
Table 106. Eli Lilly Product
Table 107. Eli Lilly Revenue in Musculoskeletal Disorders Therapeutics Business (2015-2020) (Million US$)
Table 108. Eli Lilly Recent Development
Table 109. Merck Company Details
Table 110. Merck Business Overview
Table 111. Merck Product
Table 112. Merck Revenue in Musculoskeletal Disorders Therapeutics Business (2015-2020) (Million US$)
Table 113. Merck Recent Development
Table 114. Novartis Business Overview
Table 115. Novartis Product
Table 116. Novartis Company Details
Table 117. Novartis Revenue in Musculoskeletal Disorders Therapeutics Business (2015-2020) (Million US$)
Table 118. Novartis Recent Development
Table 119. AstraZeneca Company Details
Table 120. AstraZeneca Business Overview
Table 121. AstraZeneca Product
Table 122. AstraZeneca Revenue in Musculoskeletal Disorders Therapeutics Business (2015-2020) (Million US$)
Table 123. AstraZeneca Recent Development
Table 124. Astellas Company Details
Table 125. Astellas Business Overview
Table 126. Astellas Product
Table 127. Astellas Revenue in Musculoskeletal Disorders Therapeutics Business (2015-2020) (Million US$)
Table 128. Astellas Recent Development
Table 129. AB Sciences Company Details
Table 130. AB Sciences Business Overview
Table 131. AB Sciences Product
Table 132. AB Sciences Revenue in Musculoskeletal Disorders Therapeutics Business (2015-2020) (Million US$)
Table 133. AB Sciences Recent Development
Table 134. 3SBio Company Details
Table 135. 3SBio Business Overview
Table 136. 3SBio Product
Table 137. 3SBio Revenue in Musculoskeletal Disorders Therapeutics Business (2015-2020) (Million US$)
Table 138. 3SBio Recent Development
Table 139. Samsung Bioepis Company Details
Table 140. Samsung Bioepis Business Overview
Table 141. Samsung Bioepis Product
Table 142. Samsung Bioepis Revenue in Musculoskeletal Disorders Therapeutics Business (2015-2020) (Million US$)
Table 143. Samsung Bioepis Recent Development
Table 144. Sanofi Company Details
Table 145. Sanofi Business Overview
Table 146. Sanofi Product
Table 147. Sanofi Revenue in Musculoskeletal Disorders Therapeutics Business (2015-2020) (Million US$)
Table 148. Sanofi Recent Development
Table 149. Taisho Pharmaceutical Company Details
Table 150. Taisho Pharmaceutical Business Overview
Table 151. Taisho Pharmaceutical Product
Table 152. Taisho Pharmaceutical Revenue in Musculoskeletal Disorders Therapeutics Business (2015-2020) (Million US$)
Table 153. Taisho Pharmaceutical Recent Development
Table 154. Takeda Company Details
Table 155. Takeda Business Overview
Table 156. Takeda Product
Table 157. Takeda Revenue in Musculoskeletal Disorders Therapeutics Business (2015-2020) (Million US$)
Table 158. Takeda Recent Development
Table 159. Zosano Pharma Company Details
Table 160. Zosano Pharma Business Overview
Table 161. Zosano Pharma Product
Table 162. Zosano Pharma Revenue in Musculoskeletal Disorders Therapeutics Business (2015-2020) (Million US$)
Table 163. Zosano Pharma Recent Development
Table 164. LG Life Sciences Company Details
Table 165. LG Life Sciences Business Overview
Table 166. LG Life Sciences Product
Table 167. LG Life Sciences Revenue in Musculoskeletal Disorders Therapeutics Business (2015-2020) (Million US$)
Table 168. LG Life Sciences Recent Development
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Musculoskeletal Disorders Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Biologics Features
Figure 3. Small Molecules Features
Figure 4. Global Musculoskeletal Disorders Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. Osteoarthritis Case Studies
Figure 6. Osteoporosis Case Studies
Figure 7. Psoriatic Arthritis Case Studies
Figure 8. Ankylosing Spondylitis Case Studies
Figure 9. Fibromyalgia Case Studies
Figure 10. Musculoskeletal Disorders Therapeutics Report Years Considered
Figure 11. Global Musculoskeletal Disorders Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Musculoskeletal Disorders Therapeutics Market Share by Regions: 2020 VS 2026
Figure 13. Global Musculoskeletal Disorders Therapeutics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Musculoskeletal Disorders Therapeutics Market Share by Players in 2019
Figure 16. Global Top Musculoskeletal Disorders Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Musculoskeletal Disorders Therapeutics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Musculoskeletal Disorders Therapeutics Revenue in 2019
Figure 18. North America Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. AbbVie Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2015-2020)
Figure 27. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Johnson & Johnson Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2015-2020)
Figure 29. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Amgen Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2015-2020)
Figure 31. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Pfizer Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2015-2020)
Figure 33. F. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. F. Hoffmann-La Roche Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2015-2020)
Figure 35. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Eli Lilly Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2015-2020)
Figure 37. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Merck Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2015-2020)
Figure 39. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Novartis Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2015-2020)
Figure 41. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. AstraZeneca Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2015-2020)
Figure 43. Astellas Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Astellas Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2015-2020)
Figure 45. AB Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. AB Sciences Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2015-2020)
Figure 47. 3SBio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. 3SBio Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2015-2020)
Figure 49. Samsung Bioepis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Samsung Bioepis Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2015-2020)
Figure 51. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Sanofi Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2015-2020)
Figure 53. Taisho Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Taisho Pharmaceutical Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2015-2020)
Figure 55. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Takeda Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2015-2020)
Figure 57. Zosano Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Zosano Pharma Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2015-2020)
Figure 59. LG Life Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. LG Life Sciences Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2015-2020)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed